Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheArticle : Périodique
C. HINDOCHA ; N. D. C. SHABAN ; T. P. FREEMAN ; R. K. DAS ; G. GALE ; G. SCHAFER ; C. J. FALCONER ; C. J. A. MORGAN ; H. V. CURRAN |Aims: To determine the degree to which cigarette smoking predicts levels of cannabis dependence above and beyond cannabis use itself, concurrently and in an exploratory four-year follow-up, and to investigate whether cigarette smoking mediates t[...]Article : Périodique
Aims - Use of the stimulant drug mephedrone increased dramatically in 2009, and it is still available in the United Kingdom after being controlled in April 2010. This study aimed to assess mephedrone's acute cognitive and subjective effects. De[...]Article : Périodique
B. HUGHES, Auteur ; A. R. WINSTOCK, Auteur ; K. KRAJEWSKI, Auteur du commentaire ; J. SHERIDAN, Auteur du commentaire ; B. ATMORE, Auteur du commentaire ; B. RUSSELL, Auteur du commentaire ; P. REUTER, Auteur du commentaire ; T. P. FREEMAN, Auteur du commentaire ; H. V. CURRAN, Auteur du commentaire |Aims: The rapid emergence of myriad substances openly marketed as ‘legal highs’ is straining traditional drug control systems which require time and basic scientific data on harms to react, presenting governments with the dilemma of no response [...]Article : Périodique
Background. Cannabis use is decreasing in England and Wales, while demand for cannabis treatment in addiction services continues to rise. This could be partly due to an increased availability of high-potency cannabis. Method. Adults residing in[...]Article : Périodique
ENGLISH: AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe. DESIGN: Repeated cross-sect[...]Article : Périodique
What you need to know: Cannabis based products for medicinal use contain cannabinoids derived from the cannabis plant, including Delta9-tetrahydrocananbinol (THC), cannabidiol (CBD), or a combination of THC and CBD. Synthetic cannabinoids for m[...]Article : Périodique
ENGLISH:Through the potency monitoring program at the University of Mississippi supported by National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations have been analyzed over the last decade, using a validated GC[...]Nouveauté
Article : Périodique
M. DI FORTI ; D. QUATTRONE ; T. P. FREEMAN ; G. TRIPOLI ; C. GAYER-ANDERSON ; H. QUIGLEY ; V. RODRIGUEZ ; H. E. JONGSMA ; L. FERRARO ; C. LA CASCIA ; D. LA BARBERA ; I. TARRICONE ; D. BERARDI ; A. SZOKE ; C. ARANGO ; A. TORTELLI ; E. VELTHORST ; M. BERNARDO ; C. M. DEL-BEN ; P. R. MENEZES ; J. P. SELTEN ; P. B. JONES ; J. B. KIRKBRIDE ; B. P. F. RUTTEN ; L. DE HAAN ; P. C. SHAM ; J. VAN OS ; C. M. LEWIS ; M. LYNSKEY ; C. MORGAN ; R. M. MURRAY ; EU-GEI WP2 Group |Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic[...]
